Fluicell attends Breakthrough T1D Clinical & Research Congress in Philadelphia
Fluicell attended the inaugural Breakthrough T1D Clinical & Research Congress in Philadelphia last week. Discussions centered on momentum in cell therapy for type 1 diabetes. Fluicell presented research on its islet engineering technology. Disclaimer: This news brief was created by Public Technologies (PUBT) using gene